Foundation to offer universal genomic testing for glioblastoma patients DURHAM, NC / ACCESS Newswire / December 18, 2025 / Today, the Glioblastoma Foundation announced the appointment of three ...

Phase 1 trial in aggressive brain cancer (Glioblastoma) is the first clinical trial of uTREAT® belonging to Curasight's treatment platformNo patient ...

Shuttle Pharmaceuticals Holdings, Inc. ($SHPH) announced an update on their ongoing clinical study. Study OverviewShuttle Pharmaceuticals ...

A Pennsylvania woman goes viral for her November wedding photos. However, she shares how devastating news about her fiancé’s ...

New diagnostic chip pulls packets released from tumor cells out of blood, showing whether cancer cells died during ...

The former NBA center and trailblazing gay athlete is pursuing treatment after being diagnosed with an aggressive, incurable ...

Erdafitinib showed a predictable toxicity profile and early efficacy in IDH–wild-type glioma with FGFR-TACC fusions. The recommended phase 2 dose was 8 mg daily, with one grade 3 central serous ...

Glioma remains one of the most challenging malignancies of the central nervous system, characterized by a highly ...

Research by University of Sydney scientists has uncovered a mechanism that may explain why glioblastoma returns after ...

Former Brooklyn Nets center Jason Collins recently gave a behind-the-scenes look to ESPN as he navigates his bout with brain ...

Former NBA player Jason Collins opened up about his recent brain cancer diagnosis. The 47-year-old shared he has stage 4 ...

Former NBA center Jason Collins has spoken out about his ongoing battle with brain cancer. Collins, 47, released a statement Thursday revealing that he ...